On September 26, 2021, GenScript ProBio and AskGene signed a license agreement for GenScript ProBio’s single-domain antibody (sdAb) targeting an immune checkpoint target. GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio’s sdAb targeting immune checkpoint target for discovery, development and commercialization of its antibody and derivative products. In the future, GenScript ProBio will be the preferred partner for CMC development, […]
This author has not written his bio yet.
But we are proud to say that raincastle contributed 2 entries already.
Entries by raincastle
As a subsidiary of Aosaikang Pharm (SZ002755), Askgene Pharma (AskGene) signed a patent licensing agreement (Cross-License Agreement) with Xilio Therapeutics (Xilio), the news was announced on February 19, 2021. Xilio Therapeutics is a biotechnology company developing potent, tumor-selective immunotherapies for patients with cancer located in Waltham, Massachusetts. Askgene license Xilio in the development, production and […]